1. Home
  2. Live Updates
  3. Dcgi

Live Breaking News & Updates on Dcgi

Stay informed with the latest breaking news from Dcgi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dcgi and stay connected to the pulse of your community

Alcohol content in drugs to be regulated

As part of the proposal, the government plans to amend the Drug Rules, 1945 to bring alcohol-based drug formulations under Schedule H1 from existing Schedule K drugs.

India , Rajeev-raghuvanshi , Drug-rules , Drugs-controller-general , Asia-pacific , Cosmetics-act , Aromatic-cardamom-tincture , Dcgi , Alcohol , Schedulek- , Alcohol-content

Epharmacy regulation: E-pharmacy draft rules: DCGI holds fresh talks with all stakeholders

The Drugs Controller General of India (DCGI) on Thursday held fresh consultations with stakeholders on the draft rules to regulate e-pharmacies, amid the Delhi High Court asking the government to inform it about the outcome of deliberations on the draft rules with stakeholders.

Delhi , India , Pharmacy-council-of-india , India-organization-of-chemists , Delhi-high-court , Drugs-controller-general , All-india-organization , Pharmacy-council , Cosmetic-act , Drug-acts , Epharmacy-regulation

Govt reviews medical device testing capabilities

The need for appropriate infrastructure to test medical devices is one of the government’s top priorities as mentioned in the National Medical Devices Policy, 2023.

India , National-medical-devices , National-medical-devices-policy , Medical-device , Cdsco , Dcgi , Central-drugs-standard-control-organisation , Testing-medical-devices , Task-force-report ,

Regulator tightens cough syrup test norms

In the event of a drug maker found violating the rules, government labs will not test any of their samples, Drug Controller General of India (DCGI) Rajeev Raghuvanshi has warned.

Gambia , India , Maharashtra , Ghaziabad , Uttar-pradesh , Rajeev-raghuvanshi , Central-drug-testing-laboratory , National-accreditation-board-for-testing , Indian-pharmacopoeia-commission , Drug-controller-general , National-accreditation-board , Calibration-laboratories

Drug firms move ministry over FDC ban, seek time to sell stock

FDC drugs, which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio, were recently baned by Drug Controller General of India (DCGI).

India , Daara-patel , Drug-controller-general , Chlorpheniramine-maleate , Cosmetics-act , Fdc , Dcgi , Apis , Medicines , Indian-drugs-manufacturers-association , Fixed-dose-combination-drugs

DCGI warns doctors, patients to stop using pholcodine containing cough syrups citing safety concerns

WHO warns healthcare professionals and regulatory authorities of the risk of anaphylactic reactions in the people who took pholcodine containing cough syrups and cold remedies atleast 12 months prior to surgical procedures involving the administration of general anesthesia with NMBAS

Expert-committee-antimicrobial-antiviral , Subject-expert-committee , Dcgi , Doctors , Patients , Pholcodine , Cough-syrup ,

Full provisions of medical devices regulation to come into force from October 1: DCGI

Speaking to reporters on the sidelines of the 9th International Pharmaceutical Exhibition (iPHEX) being organised by the Pharmaceuticals Exports Promotion Council (Pharmexcil) here, Raghuvanshi said the regulations would ensure quality in the production of medical devices. "In the medical devices, we are categorising into four groups. Two groups (A and B) are already notified. C and D are left which will happen from October 1," he said.

India , Ravi-udaya-bhaskar , Rajeev-singh-raghuvanshi , Union-cabinet-on , International-pharmaceutical-exhibition , Pharmaceuticals-exports-promotion-council-pharmexcil , National-medical-devices , Drugs-controller-general , Pharmaceuticals-exports-promotion-council , Union-cabinet , National-medical-devices-policy , Udaya-bhaskar

Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patients

Pti: Intas launches DCGI-approved Tofacitinib Topical (JAKi) in Auto-Immune Condition Atopic Dermatitis (AD) for Indian patients

India , Indian-railways , Press-trust-of-india , Intas , Launches , Dcgi , Approved , Tofacitinib , Topical , Jaki , In

AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India

AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.

India , Sanjeev-panchal , Astrazeneca-pharma-india-ltd-on , Astrazeneca-pharma , Cancer-treating-drug-gets-regulator , Nod-in-india , Zeneca-pharma-india-ltd , Drug-controller-general , Zeneca-pharma-india , Zeneca-india-country-president , Managing-director-sanjeev-panchal , Drug-controller-general-of-india

Covid jab Covovax to be available on CoWIN soon; to cost ₹225 per dose

Covovax is expected to be available on the portal in a few days, with a price of ₹225 per dose plus applicable GST.

United-states , India , Prakash-kumar-singh , World-health-organization , Novavax-inc , Drug-administration , Serum-institute-of-india , Health-ministry , European-medicines-agency , Serum-institute , Drugs-controller-general , Covid-jab